维奥欣治疗冠心病心绞痛的疗效观察  

作　　者：李华[1] 周春[1] 方昱[1] 

机构地区：[1]安徽省立友谊医院

出　　处：《当代医学》2009年第24期145-146,共2页Contemporary Medicine

摘　　要：目的观察维奥欣治疗冠心病心绞痛的疗效。方法112例心绞痛患者平均分为两组。治疗组56例给维奥欣;对照组56例给硝酸异山梨酯。疗程4周。观察治疗后症状及心电图变化。结果治疗组临床症状总有效率为92.6%,心电图改善总有效率为75.0%,与对照组相比,有显著性差异(P<0.05)。结论维奥欣治疗冠心病心绞痛疗效明显,可间断替代硝酸异山梨酯。Objective To observe therapeutic efficacy of Weiaoxin in patients with angina pectoris of CHD.Methods 112 patients with angina pectoris of CHD were divided into 2 groups.56 patients received Weiaoxin 160mg,po,tid, for 4 weeks.Other 56 patients received Isosorbide 10mg,po,tid,for 4 weeks.The symptoms and ECG（ischemic ST-T changes） were recorded.Results The total efficacy of Weiaoxin to the improving of angina pectoris amounted to 92.6%,that to the improving of ECG amounted to 75.0%.The therapeutic efficacy of Weiaoxin is higher than Isosorbide with significant difference between these two drugs（P〈0.05）.Conclusion Weiaoxin is effective and safe drug in treating angina pectoris as well as Isosorbide.

关 键 词：维奥欣 硝酸异山梨酯 冠心病 心绞痛 

分 类 号：R541.4[医药卫生—心血管疾病]